To demonstrate the effectiveness of A-552 on psoriasis-like changes evoked by human IL-36γ treatment, human 3D skin equivalents were treated with human IL-36γ alone and in conjunction with A-552 or anti-human IL-36R antibody as a positive control. Here, IL36G is linked to psoriasis.